In the first episode of PN London’s new podcast series around healthcare, we’re discussing Brexit’s effect. Will Britain leaving the EU hit access to key drugs for patients? Will essential Research and Development dry up after Brexit? Will the NHS be able to cope? Three leading experts examine the implications for the healthcare industry of the UK voting to leave the EU.


The panel will bring insight and perspective from patients, the pharmaceutical industry and the healthcare sector as they delve into Brexit’s impact on R&D, development of new treatments and regulation and drug approvals. This thought-provoking discussion will bring you up-to-speed with latest thinking as the industry faces unprecedented change.


Chair: Lawrence McGinty, former Science and Medical Editor, ITV News


Listen here: